Overview
- Legal name
- ARRAYSTAR INC
- Registered location
- ROCKVILLE, MD, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Jun 11, 2026
Read company summary
ARRAYSTAR INC is associated with UEI L7RMV7NK8CG5 and CAGE 64E36 in public federal records. AcornBids currently links 5 prime awards totaling $136.3K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Veterans Affairs. Its recorded federal awards include work classified as Research and Development in Biotechnology (except Nanobiotechnology); Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists ROCKVILLE, MD, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 13, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- ARRAYSTAR INC
- UEI
- L7RMV7NK8CG5
- CAGE
- 64E36
- Registered address
- 9430 KEY WEST AVE STE 128, ROCKVILLE, MD, 20850, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Nov 6, 2025
- Initial registration
- Aug 27, 2010
- Entity start
- Jan 4, 2009
- SAM updated
- Nov 6, 2025
- Registration expires
- Nov 4, 2026
- Fiscal year end
- Dec 31
- Place of incorporation
- MD, USA
Research brief
Source facts
- Loaded prime-award records link 5 awards and $136,332 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in Biotechnology (except Nanobiotechnology) (NAICS 541714); this classification is not proof of every company capability. Source
- An example award describes: EXOSOME MI RNA PROFILING AND SEQUENCING SERVICE Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 5 of 5 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $-19.3K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $77.7K |
| Change | $-97.0K |
| Growth | -124.8% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Veterans Affairs | $77.7K | 1 |
| Department of Health and Human Services | $42.1K | 4 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| 252-NETWORK CONTRACT OFFICE 12 (36C252) | $77.7K | 1 |
| NIH NCI | $22.2K | 1 |
| NATIONAL INSTITUTES OF HEALTH NHLBI | $15.0K | 1 |
| FDA OFFICE OF ACQ GRANT SVCS | $5.0K | 2 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | $121.4K | 3 |
| 541711 | $15.0K | 1 |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | $-16.5K | 1 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| AN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $77.7K | 1 |
| Q301 — Reference Laboratory Testing | $22.2K | 1 |
| B504 — Chemical/Biological Studies and Analysis | $21.5K | 1 |
| 6505 — Drugs and Biologicals | $15.0K | 1 |
| AN21 — HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; BASIC RESEARCH | $-16.5K | 1 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $119.8K | 5 |
States
| Category | Period obligations | Awards |
|---|---|---|
| MD | $119.8K | 5 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| NO SET ASIDE USED. | $104.8K | 4 |
| SMALL BUSINESS SET ASIDE - TOTAL | $15.0K | 1 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75F40123P00431EXOSOME MI RNA PROFILING AND SEQUENCING SERVICE | Department of Health and Human Services | $0 | Sep 19, 2023 | Apr 25, 2024 |
| 75N91021P00530LAB TESTING SERVICES | Department of Health and Human Services | $22.2K | Jun 14, 2021 | Jul 14, 2021 |
| 36C25225C0011DR VEMUGHANTI - METHYLATED AND HYDROXYMETHYLATED DNA IMMUNOPRECIPITATION SEQUENCING | Department of Veterans Affairs | $77.7K | Mar 1, 2025 | Aug 31, 2025 |
| 75F40123P00138THIS IS A FIRM FIXED PRICE PURCHASE ORDER TO ACQUIRE TRANSFER RNAS (TRNAS) SEQUENCING SERVICE. | Department of Health and Human Services | $21.5K | Aug 1, 2023 | Jul 31, 2024 |
| HHSN268201600296AIGF::OT::IGF | Department of Health and Human Services | $15.0K | Sep 19, 2016 | Nov 19, 2016 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Nov 6, 2025 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Aug 27, 2010 |
| Entity start | Jan 4, 2009 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| MARK GUI | Government business | Contact method not published | SAM registration | Not available |
| PING ZHU ZHU | Alternate government business | Contact method not published | SAM registration | Not available |
| MARK GUI | Electronic business | Contact method not published | SAM registration | Not available |
| MARC ROGERS | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit